Rapid Response® Point of Care Drugs of Abuse Tests

Published May 25, 2010

Toronto, Canada â BTNX Inc. has launched a series of Rapid ResponseÂ® advanced FDA approved point of care in-vitro diagnostic drugs of abuse tests, which are used for home, professional and corporation point of care drugs of abuse testing.

The drug tests can easily detect any of Amphetamine, Barbiturate, Benzodiazepine, Buprenorphine, Cocaine, Ecstasy, EDDP (Methadone Metabolite), Heroin, Marijuana, Methadone, Methamphetamine, Morphine, Opiate, Â Â Oxycodone, Phencyclidine, Â Propoxyphene, Tricyclic Antidepressant. Or any combinations range from 1 test panel to 12 test panels.

Rapid Response Â® point of care drugs of abuse test series includes urine drug test cups, urine drug test panels, urine drug test strips, urine drug test cassettes, saliva drug tests and lab hair drug tests.

Rapid ResponseÂ® branded point of care drugs of abuse tests are trusted by professionals in laboratories, physiciansâ offices, hospitals and clinics worldwide for their diagnostic testing requirements.

BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. BTNX Inc. specializes in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests and information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions for laboratories, clinics, hospitals and physiciansâ offices.

BTNX focuses on providing its distributors with the highest quality products at competitive pricing, to increase distributor margins. This is accomplished by building strategic alliances with the most advanced innovative manufacturing facilities, combined with a high caliber team of professionals, BTNX has developed an extremely efficient product development and sourcing infrastructure that is able to deliver real value to its customers.

BTNX Inc. distributes its products under the Rapid Response brand and is also a certified Original Equipment Manufacturer (OEM) of rapid diagnostic tests. We have established an international reputation for excellence in the manufacturing of quality medical diagnostic test kits.

For more information about the products please click Rapid Response Drug Tests, or contact [email protected].

BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. BTNX Inc. specializes in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests and information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions for laboratories, clinics, hospitals and physiciansâ offices.

Rapid Response® Point of Care Drugs of Abuse Tests

Related Drug Addiction Blogs